Lysyl oxidase (LOX) and hypoxia-induced metastases

Amy M. Sion, William D. Figg*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

22 Scopus citations


Angiogenesis is a critical process in the transition of tumors from a localized, primary site to a distant site of metastases. Hypoxic conditions within the tumor mass lead to the activation of signalling pathways which initiate tumor cell invasion, migration, adhesion and subsequent angiogenesis. Several key molecular players in hypoxia-induced tumor progression are well-described, e.g., hypoxia-inducible factor-1 (HIF-1) and angiopoietin-2; however, drug development aimed at suppressing individual members of this signalling cascade has proven to be challenging. The article by Erler et al. published in Nature (Vol. 440, April 2006) identifies lysyl oxidase (LOX) as an essential enzyme for hypoxia -induced metastases. This Journal Club reviews the findings presented by Erler and colleagues and briefly discusses the implications of LOX in cancer.

Original languageEnglish
Pages (from-to)909-911
Number of pages3
JournalCancer Biology and Therapy
Issue number8
StatePublished - Aug 2006
Externally publishedYes


  • Adhesion
  • HIF
  • Hypoxia
  • Invasion
  • LOX
  • Metastases


Dive into the research topics of 'Lysyl oxidase (LOX) and hypoxia-induced metastases'. Together they form a unique fingerprint.

Cite this